Brokerages Set UnitedHealth Group Incorporated (NYSE:UNH) PT at $627.74

UnitedHealth Group Incorporated (NYSE:UNH) has received an average recommendation of “Buy” from the twenty-two ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, nineteen have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $629.32.

UNH has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Stephens boosted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Bank of America lowered their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Dark Forest Capital Management LP grew its stake in shares of UnitedHealth Group by 76.9% during the 2nd quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock valued at $374,000 after buying an additional 319 shares during the period. Scientech Research LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth approximately $1,071,000. Sepio Capital LP grew its stake in UnitedHealth Group by 0.3% during the second quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after buying an additional 20 shares during the period. Texas Capital Bank Wealth Management Services Inc raised its stake in shares of UnitedHealth Group by 6.6% in the 2nd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock valued at $8,216,000 after acquiring an additional 994 shares during the period. Finally, Kathmere Capital Management LLC boosted its position in UnitedHealth Group by 25.1% during the 2nd quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock worth $2,428,000 after purchasing an additional 958 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.3 %

NYSE:UNH opened at $545.29 on Friday. The stock has a 50-day simple moving average of $538.18 and a 200-day simple moving average of $565.09. The stock has a market cap of $501.82 billion, a P/E ratio of 35.18, a P/E/G ratio of 1.41 and a beta of 0.62. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the firm earned $5.83 EPS. The company’s revenue was up 6.8% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.